{rfName}
Pr

Indexed in

Citations

22

Altmetrics

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Mullol, JoaquimCorresponding AuthorAlobid, IsamAuthor

Share

February 21, 2025
Publications
>
Article
No

Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in Spain

Publicated to: Rhinology. 62 (4): 421- - 2024-01-01 62(4), DOI: 10.4193/Rhin23.341

Authors:

Mullol, Joaquim; Sastre, Joaquin; Dominguez-Ortega, Javier; Blanco-Aparicio, Marina; Vizuete, Jose Antonio Castillo; Alobid, Isam; Garcia-Vitoria, Montse; Palomo-Jimenez, Paloma I; Palomo-Jimenez, Paloma I
[+]

Affiliations

Hosp Univ Dexeus, Dept Resp Med, Barcelona, Catalonia, Spain - Author
La Coruna Univ Hosp, Asthma Unit, La Coruna, Galicia, Spain - Author
Las Paz Univ Hosp, Inst Hlth Res IdiPAZ, Dept Allergol, Madrid, Madrid, Spain - Author
Sanofi, Barcelona, Catalonia, Spain - Author
Sanofi, Madrid, Madrid, Spain - Author
Univ Autonoma Madrid, Fac Med, CIBER Enfermedades Respiratorias CIBERES, Dept Allergol,Fdn Jimenez Diaz, Madrid, Madrid, Spain - Author
Univ Barcelona, Hosp Clin, ENT Dept, Rhinol Unit,FRCB IDIBAPS,CIBERES, Barcelona, Catalonia, Spain - Author
Univ Barcelona, Hosp Clin, Smell Clin, FRCB IDIBAPS,CIBERES,ENT Dept, Barcelona, Catalonia, Spain - Author
Univ Barcelona, Rhinol & Skull Base Unit, FRCB IDIBAPS, ENT Dept,Hosp Clin,CIBERES, Barcelona, Catalonia, Spain - Author
See more

Abstract

Background: : The worldwide prevalence range of chronic rhinosinusitis (CRS) is 5-12%; from this, 20 % have nasal polyps. Due to the little epidemiological data about CRS in the Spanish population, this study analyses the prevalence and severity of CRS with (CRSwNP) or without (CRSsNP) nasal polyps, and their connection with other coexisting type 2 inflammatory diseases in Spain. Methodology: : This is a retrospective, large-scale, nationwide, epidemiological study based on the electronic medical records from the BIG-PAC (R) database. Patients diagnosed of CRSsNP and CRSwNP were identified using specific disease codes. The severe form of the disease was defined as patients who received at least a long course of antibiotics in CRSsNP or >= 2 short courses of systemic corticosteroids in CRSwNP in = 18 years old), 42,863 and 7,550 patients with diagnosed CRSsNP and CRSwNP, respectively, were analysed. The overall prevalence of diagnosed CRS was 5.1%, being 4.3% and 0.8% for CRSsNP and CRSwNP, respectively. Patients with CRSwNP and severe forms of the disease were older and had higher levels of type 2 inflammatory biomarkers than CRSsNP patients and non-severe disease. Conclusions: : Although CRSsNP was more prevalent than CRSwNP, the severe forms of CRS were more frequent in patients with CRSwNP. In addition, CRSwNP patients had a higher incidence of coexisting type 2 inflammatory diseases.
[+]

Keywords

AdolescentAdultAllergyAsthmaChronic diseaseChronic rhinosinusitisComorbidityComplicationDiseaseEosinophiliaEpidemiologyFemaleGood health and well-beingHumanHumansMaleMiddle agedNasal polypsPrevalenceRetrospective studiesRetrospective studyRhinitisRhinosinusitisSeverity of illness indexSinonasal polypSinus surgerySinusitisSpainType-2 inflammatioType-2 inflammationYoung adult

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal RHINOLOGY due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2024 there are still no calculated indicators, but in 2023, it was in position 1/67, thus managing to position itself as a Q1 (Primer Cuartil), in the category Otorhinolaryngology. Notably, the journal is positioned above the 90th percentile.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2026-04-04:

  • Open Alex: 1
  • WoS: 6
  • Scopus: 2
  • Europe PMC: 2
[+]

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2026-04-04:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 40.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 40 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 13.
  • The number of mentions on the social network X (formerly Twitter): 1 (Altmetric).
  • The number of mentions in news outlets: 1 (Altmetric).
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Good Health And Well-being, with a probability of 84% according to the mBERT algorithm developed by Aurora University.
[+]

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Mullol i Miret, Joaquim) .

the author responsible for correspondence tasks has been Mullol i Miret, Joaquim.

[+]

Awards linked to the item

This study was funded by Sanofi.
[+]